Akanda (Akanda) Additional Paid-In Capital : $0.00 Mil(As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Akanda Additional Paid-In Capital?

Akanda Additional Paid-In Capital Historical Data

The historical data trend for Akanda's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akanda Additional Paid-In Capital Chart

Akanda Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Akanda Quarterly Data
	Dec19	Sep20	Dec20	Jun21	Sep21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial					-	0.58	-	-	-

Akanda Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Akanda Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Akanda's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Akanda (Akanda) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akanda Corp (NAS:AKAN) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

Y230:Germany

Address

1A, 1B Learoyd Road, New Romney, GBR, TN28 8XU

Website

https://www.akandacorp.com

Akanda Corp is a cannabis cultivation, manufacturing and distribution company. The Company has three reportable segments: Cultivation, Distribution and Corporate. Cultivating activities comprise the cultivation segment is made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.